Galecto Inc

NASDAQ:GLTO  
0.68
-0.04 (-5.35%)
6:19:04 PM EDT: $0.68 0.00 (-0.06%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Galecto Inc Stock, NASDAQ:GLTO

75 State Street, Suite 100, Boston, Massachusetts 02109
United States of America
Phone: +1.45.070.5210
Number of Employees: 13
http://www.galecto.com

Description

Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3, lysyl oxidase-like 2, and LOXL2. The company was founded by Ulf J�¶rgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsg�¥rd Schambye in 2011 and is headquartered in Boston, MA.